- By Ely Marquez
- (General Dispatch) – Accusations directed at Joe Biden’s administration claim that the current administration has millions of unused vaccines in storage.
- This fact has generated an aggressive offer for the U.S. territory of vaccines, while other companies are looking for ways to produce vaccines and establish a competitive scenario like Russia and China.
- The AstraZeneca brand, assures that U.S. vaccine production is aimed at its own population and not at supplying the international market.
- The European Union, for its part, has been in constant communication with the U.S. government requesting a share of the vaccines through commercial exchanges.
- It is expected that 30 million doses will be available by the end of the month, and another 20 million by April.
- Health experts seem to have confidence in the U.S. covid-19 vaccine brands, as demand is steady from neighboring countries.
- Nevertheless, the companies have distributed at least 34 million doses of the coronavirus vaccine to several European Union countries.
- Prospectively, U.S. companies are stocking up on raw materials to manufacture and distribute the projections demanded in the following months.
Adittional Information:
Ap News: Conflict grows between US and allies over vaccine supply
